Moneycontrol
Get App
Last Updated : Jul 12, 2019 04:29 PM IST | Source: Moneycontrol.com

Aurobindo Pharma Q1 PAT seen up 11.2% YoY to Rs. 506.7 cr: Prabhudas Lilladher

Net Sales are expected to increase by 16.3 percent Y-o-Y (down 6.5 percent Q-o-Q) to Rs. 4,863 crore, according to Prabhudas Lilladher.

Moneycontrol News @moneycontrolcom
Representative image
Representative image

Prabhudas Lilladher has come out with its first quarter (April-June’ 19) earnings estimates for the Pharma sector. The brokerage house expects Aurobindo Pharma to report net profit at Rs. 506.7 crore up 11.2% year-on-year (down 18.5% quarter-on-quarter).


Net Sales are expected to increase by 16.3 percent Y-o-Y (down 6.5 percent Q-o-Q) to Rs. 4,863 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 10.1 percent Y-o-Y (down 19.3 percent Q-o-Q) to Rs. 782.4 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jul 12, 2019 04:29 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant